Hadassah

Hadassah Physician Advocates Successfully for Insurance Coverage of Medicine to Save Infant

Monday, Jan 30 2017

Prof. Shimon Reif, head of the Department of Pediatrics at Hadassah Hospital Ein Kerem.

Prof. Shimon Reif, head of the Department of Pediatrics at Hadassah Hospital Ein Kerem, successfully advocated for health insurance coverage of a medicine that a two-month-old baby with a rare metabolic disease needed to survive.

The baby’s genetic condition leads to her inability to metabolize fats. As Prof. Reif recently explained on Israeli radio, orphan diseases like this rarely have cures and when they do, the costs are very high because the medicine will only be needed for a small number of patients. The cost of this enzyme therapy called Kanuma is half a million shekels a year.

Appearing in the first weeks of life, the disease, called lysosomal acid lipase deficiency, impacts all bodily systems. The child experiences digestive and liver problems and fails to grow and is expected to live only a few months without the medication.

The Jerusalem baby's two older sisters, who were born with the same disease, both died. "This baby was brought to us when she was two months old," relates Prof. Reif. "Because of the terrible family history, we immediately did genetic testing."

Although the health basket committee had discussed approval of this medicine in October, at the time, there were no cases in Israel. “We thank God for the decision,” said the baby’s father. “We hope our daughter will now be able to grow and develop."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Aug 15 2019

Argentinian Neurosurgeon Shares His Love for Working at Hadassah

Many years ago, neurosurgeon Andrés Vargas, born in Tucumán, Argentina, chose to live in Israel and practice medicine at Hadassah Hospital Ein Kerem.

READ MORE ›
alt_text

Wednesday, Aug 14 2019

A Hadassah Cystic Fibrosis Expert Advises the Panamanian Government

Dr. Malena Cohen, a pediatric pulmonary specialist at the Hadassah Medical Organization, traveled to Panama last week to explore the idea of opening the first cystic fibrosis (CF) center there.

READ MORE ›
alt_text

Tuesday, Aug 13 2019

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

The Hadassah Medical Organization, through its subsidiary SRY, has contracted to be the sole Israeli agent for General Electric to produce Vizamy, the company’s new radioactive imaging agent to detect, at an early stage, amyloid plaque, which has been linked to the development of Alzheimer’s disease.

READ MORE ›
alt_text

Friday, Aug 2 2019

New Thyroid Eye Disease Clinic at Hadassah Brings Integrated Care to New Mom

Miriam, 34, had just given birth to her third child, and, unlike the joy she felt after her first two births, she felt awful.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More